Regulation, legislation & enforcement

ODSP’s director on NDIs, MPL, and NMN

ODSP’s director on NDIs, MPL, and NMN

By Danielle Masterson

NutraIngredients-USA caught up with Cara Welch, PhD, Director of FDA's Office of Dietary Supplement Programs. Welch talked inspections, made the case for MPL and hinted NDI guidance is on the way.

CRN: NDI guidance is 'doable'

CRN: NDI guidance is 'doable'

By Danielle Masterson

NutraIngredients-USA caught up with CRN’s Steve Mister at SupplySide East to discuss new research, top priorities for the year and what they hope to see from FDA this year.

Image courtesy of Ritual

Ritual debuts at Target

By Danielle Masterson

As if we need another reason to shop at Target, Ritual’s top products are now on the shelves of the go-to destination for everyday essentials.

Probiota Americas: Early bird discount expires this week

Probiota Americas: Early bird discount expires this week

With expert speakers confirmed from NOW, Nouri, Postbiotics+, Microba, Zbiotics, NC State University, FDA, Health Canada, the University of Nebraska-Lincoln, and more, the upcoming Probiota Americas is not to be missed.

State of the US Dietary Supplements sector in 2023

STATE OF THE INDUSTRY SURVEY

State of the US Dietary Supplements sector in 2023

By Stephen Daniells

Are supply chains still causing problems for businesses? What are the hottest ingredients and most sought-after product claims? And do people really think about FDA’s recent actions against ingredients like NAC and NMN?

Lawsuit against FDA on NMN ‘certainly being considered’, says NPA CEO

Lawsuit against FDA on NMN ‘certainly being considered’, says NPA CEO

By Stephen Daniells

The Natural Products Association is hoping the US Food & Drug Administration is responsive to its recent Citizen’s Petition on the status of NMN, but if it’s not then other options are being considered, Dr Daniel Fabricant, NPA’s CEO tells NutraIngredients-USA.

What to expect from the International Conference on the Science of Botanicals

Oxford ICSB: ‘You always learn something from this meeting’

By Stephen Daniells

From authentication and identification of botanicals to approached to establishing safety and efficacy, the 21st International Conference on the Science of Botanicals (ICSB) provides stakeholders in the botanicals space a unique opportunity to learn and...

Steve Mister on FDA, MPL, CBD, and CRN at 50

Steve Mister on proposed FDA reorg, MPL, CBD, and CRN at 50

By Stephen Daniells

The first month of 2023 is over, and already there’s some big developments (or non-developments in the case of CBD) for the US dietary supplements industry. We caught up with Steve Mister, president and CEO of the Council for Responsible Nutrition, to...

5 take-aways we learned during our Business Leaders Forum

5 take-aways we learned during our Business Leaders Forum

By Stephen Daniells

From 2022 sales numbers to consumer enthusiasm remaining high, and from progress with equality and diversity in the industry to the growth in awareness around the importance of the microbiome for health, there were lots of talking points from our 3rd...

Getty Images / skynesher

Drumroll, please… waiting game continues to plague CBD industry

By Danielle Masterson

Rumors about a big FDA announcement began swirling earlier this week, with the industry bracing for a potential end to a five-year wait on the regulatory future of CBD. But, much like the last few years, CBD professionals were left waiting without answers,...

©Getty Images - JStudios

MusclePharm assets to be sold at auction

By Hank Schultz

The intellectual property of MusclePharm, a sports nutrition brand that had a meteoric rise and an equally spectacular fall, will be sold at an auction on Thursday, Dec. 15.

Follow us

Products

View more

Webinars